AHCO vs. HIMS, RDNT, OPCH, GH, SHC, VCYT, BTSG, LFST, SGRY, and CON
Should you be buying AdaptHealth stock or one of its competitors? The main competitors of AdaptHealth include Hims & Hers Health (HIMS), RadNet (RDNT), Option Care Health (OPCH), Guardant Health (GH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry.
AdaptHealth vs.
AdaptHealth (NASDAQ:AHCO) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends, community ranking and analyst recommendations.
AdaptHealth received 42 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 61.03% of users gave AdaptHealth an outperform vote while only 39.05% of users gave Hims & Hers Health an outperform vote.
82.7% of AdaptHealth shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 4.4% of AdaptHealth shares are owned by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Hims & Hers Health has lower revenue, but higher earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
AdaptHealth presently has a consensus target price of $12.40, indicating a potential upside of 17.87%. Hims & Hers Health has a consensus target price of $25.13, indicating a potential downside of 9.60%. Given AdaptHealth's stronger consensus rating and higher probable upside, equities research analysts clearly believe AdaptHealth is more favorable than Hims & Hers Health.
In the previous week, Hims & Hers Health had 23 more articles in the media than AdaptHealth. MarketBeat recorded 24 mentions for Hims & Hers Health and 1 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 1.50 beat Hims & Hers Health's score of 0.54 indicating that AdaptHealth is being referred to more favorably in the media.
AdaptHealth has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500.
Hims & Hers Health has a net margin of 8.19% compared to AdaptHealth's net margin of -6.57%. Hims & Hers Health's return on equity of 10.97% beat AdaptHealth's return on equity.
Summary
Hims & Hers Health beats AdaptHealth on 11 of the 18 factors compared between the two stocks.
Get AdaptHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for AHCO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AdaptHealth Competitors List
Related Companies and Tools
This page (NASDAQ:AHCO) was last updated on 1/21/2025 by MarketBeat.com Staff
Free AHCO Stock Alerts